Amount Raised
$20 Million
Round Type
Series A
Description
Maryland-based biotech company Deka Biosciences ("Deka") today announced that it has successfully closed a USD 20 Million Series A financing with a syndicate of life science investors led by Leaps by Bayer, the impact investment arm of Bayer AG, and new investor Lumira Ventures. Additional investors include O-Bio (Echo Investment Capital), Viva BioInnovator, and Alexandria Venture Investments.
Quick answer
Deka Biosciences, Inc. raised $20 Million in a Series A round, dated November 16, 2021. Deka Biosciences, Inc. is based in Germantown, Illinois, United States.
- How much did Deka Biosciences, Inc. raise?
- Deka Biosciences, Inc. raised $20 Million in a Series A round on November 16, 2021.
- What does Deka Biosciences, Inc. do?
- Deka is an early-stage biotech company focused on the development of novel cytokine therapies to treat cancer and inflammatory diseases such as Crohn's, psoriasis, rheumatoid arthritis and sepsis.
- Where is Deka Biosciences, Inc. based and how big is it?
- Deka Biosciences, Inc. is based in Germantown, Illinois, United States.
- Who are the decision-makers at Deka Biosciences, Inc?
- Fundz holds 1 contact at Deka Biosciences, Inc., including the Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Deka Biosciences, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Trait Biosciences Inc. raised an undisclosed amount (Series A) on December 30, 2021.
- TandemAI raised $25M (Seed) on December 22, 2021.
- Appili Therapeutics Inc. raised an undisclosed amount (Funding Round) on December 22, 2021.
- 20n Bio raised $3.3M (Seed) on December 17, 2021.
- Specific Biologics raised an undisclosed amount (Seed) on December 16, 2021.
- Mythic Therapeutics raised an undisclosed amount (Series B) on December 15, 2021.
Who to call at Deka Biosciences, Inc., and when
A new round usually means Deka Biosciences, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Deka Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Deka Biosciences, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Deka Biosciences, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Deka Biosciences, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansDeka Biosciences, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.